Treatment Adherence Among Patients with Five Dermatological Diseases and Four Treatment Types - a Cross-Sectional Study

References

• Feldman SR, Horn EJ, Balkrishnan R, et al. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol. 2008;59(6):1009–1016. doi:10.1016/j.jaad.2008.08.02818835062
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.19146365
   PubMed Web of Science ®Google Scholar
• Al-Qazaz H, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216–221. doi:10.1016/j.diabres.2010.08.01220832888
   PubMed Web of Science ®Google Scholar
• Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis. 2011;17(2):599–604. doi:10.1002/ibd.2131020848512
   PubMed Web of Science ®Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. doi:10.1136/bmjopen-2017-016982
   PubMed Web of Science ®Google Scholar
• Torrelo A, Ortiz J, Alomar A, Ros S, Pedrosa E, Cuervo J. Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study. Actas Dermosifiliogr. 2013;104(5):409–417. doi:10.1016/j.ad.2012.12.00323665434
   PubMedGoogle Scholar
• Conlon NP, Edgar JD. Adherence to best practice guidelines in chronic spontaneous urticaria (CSU) improves patient outcome. Eur J Dermatol. 2014;24(3):385–386. doi:10.1684/ejd.2014.232324682625
   PubMed Web of Science ®Google Scholar
• Snyder S, Crandell I, Davis SA, Feldman SR. Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol. 2014;15(2):87–94. doi:10.1007/s40257-014-0063-y24481999
   PubMed Web of Science ®Google Scholar
• Zschocke I, Mrowietz U, Karakasili E, Reich K. Non-adherence and measures to improve adherence in the topical treatment of psoriasis. J Eur Acad Dermatol Venereol. 2014;28(Suppl 2):4–9. doi:10.1111/jdv.2014.28.issue-s224684738
   PubMed Web of Science ®Google Scholar
• Richards HL, Fortune DG, Griffiths CE. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006;20(4):370–379. doi:10.1111/jdv.2006.20.issue-416643132
   PubMed Web of Science ®Google Scholar
• Ichiyama S, Ito M, Funasaka Y, et al. Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities. J Dermatol. 2018;45(6):727–731. doi:10.1111/jde.2018.45.issue-629356075
   PubMed Web of Science ®Google Scholar
• Tan X, Al-Dabagh A, Davis SA, et al. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. Am J Clin Dermatol. 2013;14(3):243–251. doi:10.1007/s40257-013-0016-x23572294
   PubMed Web of Science ®Google Scholar
• Furue M, Onozuka D, Takeuchi S, et al. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol. 2015;172(1):272–275. doi:10.1111/bjd.2015.172.issue-125154923
   PubMed Web of Science ®Google Scholar
• Saeki H, Imafuku S, Abe M, et al. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015;42(4):367–372. doi:10.1111/jde.2015.42.issue-425720544
   PubMed Web of Science ®Google Scholar
• Doshi JA, Takeshita J, Pinto L, et al. Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. J Am Acad Dermatol. 2016;74(6):1057–1065.e1054. doi:10.1016/j.jaad.2016.01.04826946986
   PubMed Web of Science ®Google Scholar
• Hsu DY, Gniadecki R. Patient adherence to biologic agents in psoriasis. Dermatology. 2016;232(3):326–333. doi:10.1159/00044458127093295
   PubMed Web of Science ®Google Scholar
• Chan SA, Hussain F, Lawson LG, Ormerod AD. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J Dermatolog Treat. 2013;24(1):64–69. doi:10.3109/09546634.2011.60742521797808
   PubMed Web of Science ®Google Scholar
• Evers AW, Kleinpenning MM, Smits T, et al. Treatment nonadherence and long-term effects of narrowband UV-B therapy in patients with psoriasis. Arch Dermatol. 2010;146(2):198–199. doi:10.1001/archdermatol.2009.38220157036
   PubMedGoogle Scholar
• Kalia S, Toosi B, Bansback N, et al. Assessing adherence with phototherapy protocols. J Am Acad Dermatol. 2014;71(6):1259–1261. doi:10.1016/j.jaad.2014.07.04625454035
   PubMed Web of Science ®Google Scholar
• Abraham S, Raghavan P. Myths and facts about vitiligo: an epidemiological study. Indian J Pharm Sci. 2015;77(1):8–13. doi:10.4103/0250-474X.15157325767313
   PubMed Web of Science ®Google Scholar
• Kandaswamy S, Akhtar N, Ravindran S, Prabhu S, Shenoi SD. Phototherapy in vitiligo: assessing the compliance, response and patient’s perception about disease and treatment. Indian J Dermatol. 2013;58(4):325. doi:10.4103/0019-5154.113944
   PubMedGoogle Scholar
• Ueno H, Yamazaki Y, Yonekura Y, Park MJ, Ishikawa H, Kiuchi T. Reliability and validity of a 12-item medication adherence scale for patients with chronic disease in Japan. BMC Health Serv Res. 2018;18(1):592. doi:10.1186/s12913-018-3380-730064422
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Cronbach’s alpha. BMJ. 1997;314(7080):572. doi:10.1136/bmj.314.7080.5729055718
   PubMed Web of Science ®Google Scholar
• Tsunemi Y, Abe S, Kobayashi M, et al. Adherence to oral and topical medication in 445 patients with tinea pedis as assessed by the Morisky Medication Adherence Scale-8. Eur J Dermatol. 2015;25(6):570–577. doi:10.1684/ejd.2015.265026574949
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology. 2000;200(4):292–298. doi:10.1159/00001839010894958
   PubMed Web of Science ®Google Scholar
• Wang W, Qiu Y, Zhao F, Zhang F. Poor medication adherence in patients with psoriasis and a successful intervention. J Dermatolog Treat. 2019;30(6):525–528. doi:10.1080/09546634.2018.147665229790405
   PubMed Web of Science ®Google Scholar
• Patel N, Feldman SR. Adherence in atopic dermatitis. Adv Exp Med Biol. 2017;1027:139–159.29063437
   PubMed Web of Science ®Google Scholar
• Ali MA, Abou-Taleb DA, Mohamed RR. Treatment adherence and beliefs about medicines among Egyptian vitiligo patients. Dermatol Ther. 2016;29(6):413–418. doi:10.1111/dth.1239727594551
   PubMed Web of Science ®Google Scholar
• Hayran Y, Incel Uysal P, Oktem A, Aksoy GG, Akdogan N, Yalcin B. Factors affecting adherence and patient satisfaction with treatment: a cross-sectional study of 500 patients with acne vulgaris. J Dermatolog Treat. 2019;1–6. doi:10.1080/09546634.2019.1618434
   Web of Science ®Google Scholar
• Murota H, Takeuchi S, Sugaya M, et al. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation. J Dermatol Sci. 2015;79(3):279–287. doi:10.1016/j.jdermsci.2015.05.01026255207
   PubMed Web of Science ®Google Scholar
• Sevimli Dikicier B. Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate. J Int Med Res. 2019;47(7):2987–2992. doi:10.1177/030006051984736731122106
   PubMed Web of Science ®Google Scholar